Oramed Pharmaceuticals Inc. (ORMP) SEC filings

ORMP SEC filings moved a median of +0.93% by the close. ORMP SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the ORMP overview →

62 measured ORMP SEC filing events.

Where these ORMP SEC filings landedvs 62 measured ORMP SEC filing reactions
ORMP SEC filingMiddle 50% · -0.52% to +2.14%Zero: 0.00%Median: +0.93%Median +0.93%-3.00%0+3.00%
Middle 50% of ORMP SEC filing reactions-0.52% to +2.14%
Median reaction (to close)+0.93%
Measured reactions62
Point-in-time · zero look-ahead

Half of the 62 ORMP SEC filing events with a measured close landed between -0.52% and +2.14%; 65% closed up.

DateHeadlineEvent5-minTo close
Form 8-K ORAMED PHARMACEUTICALS For: Sep 15SEC filing · Form 8-K—-0.21%
Form 10-Q ORAMED PHARMACEUTICALS For: Jun 30SEC filing · Form 10-Q+1.43%+0.95%
Form ARS ORAMED PHARMACEUTICALS For: Dec 31SEC filing · Form ARS-0.11%+1.83%
Form DEF 14A ORAMED PHARMACEUTICALS For: Sep 15SEC filing · Form DEF-0.11%+1.83%
Form DEFA14A ORAMED PHARMACEUTICALSSEC filing · Form DEFA14A-0.11%+1.83%
Form 8-K ORAMED PHARMACEUTICALS For: Jun 25SEC filing · Form 8-K-4.63%-2.95%
Form 10-Q ORAMED PHARMACEUTICALS For: Mar 31SEC filing · Form 10-Q-1.17%+0.47%
Form NT 10-Q ORAMED PHARMACEUTICALS For: Mar 31SEC filing · Form NT+0.86%-7.34%
Form 8-K ORAMED PHARMACEUTICALS For: Mar 25SEC filing · Form 8-K+1.46%-0.88%
Form 10-K ORAMED PHARMACEUTICALS For: Dec 31SEC filing · Form 10-K+2.13%+0.61%
Form 8-K ORAMED PHARMACEUTICALS For: Feb 19SEC filing · Form 8-K+0.76%+2.48%
Form 8-K ORAMED PHARMACEUTICALS For: Jan 12SEC filing · Form 8-K-0.54%-0.54%
Form 8-K ORAMED PHARMACEUTICALS For: Jan 07SEC filing · Form 8-K+2.55%+4.14%
Form 8-K ORAMED PHARMACEUTICALS For: Dec 30SEC filing · Form 8-K+0.00%+1.79%
Form 8-K ORAMED PHARMACEUTICALS For: Dec 31SEC filing · Form 8-K-1.05%+1.75%
Form 8-A12B ORAMED PHARMACEUTICALSSEC filing · Form 8-A12B+0.22%+1.74%
Form 8-K ORAMED PHARMACEUTICALS For: Nov 16SEC filing · Form 8-K+0.22%+1.74%
Form 8-K ORAMED PHARMACEUTICALS For: Nov 17SEC filing · Form 8-K+0.22%+1.74%
Form 8-K ORAMED PHARMACEUTICALS For: Oct 20SEC filing · Form 8-K-0.42%+0.84%
Form 8-K ORAMED PHARMACEUTICALS For: Sep 30SEC filing · Form 8-K+0.82%+0.82%
Form 8-K ORAMED PHARMACEUTICALS For: Aug 19SEC filing · Form 8-K+0.00%+3.38%
Form S-8 ORAMED PHARMACEUTICALSSEC filing · Form S-8+0.00%+3.38%
Form 10-Q ORAMED PHARMACEUTICALS For: Jun 30SEC filing · Form 10-Q+4.25%+4.00%
Form 8-K ORAMED PHARMACEUTICALS For: Jul 22SEC filing · Form 8-K+0.00%+7.98%
Form 10-K/A ORAMED PHARMACEUTICALS For: Dec 31SEC filing · Form 10-K+0.00%+0.00%
Form ARS ORAMED PHARMACEUTICALS For: Dec 31SEC filing · Form ARS+0.00%+0.00%
Form DEF 14A ORAMED PHARMACEUTICALS For: Aug 19SEC filing · Form DEF+0.00%+0.00%
Form 8-K ORAMED PHARMACEUTICALS For: May 21SEC filing · Form 8-K+0.47%+1.90%
Form 10-Q ORAMED PHARMACEUTICALS For: Mar 31SEC filing · Form 10-Q+0.91%-2.27%
Form 8-K ORAMED PHARMACEUTICALS For: Apr 24SEC filing · Form 8-K+0.00%+4.48%
Form 10-K ORAMED PHARMACEUTICALS For: Dec 31SEC filing · Form 10-K+0.00%-4.74%
Form 8-K ORAMED PHARMACEUTICALS For: Feb 28SEC filing · Form 8-K-2.00%+7.00%
Form 8-K ORAMED PHARMACEUTICALS For: Feb 22SEC filing · Form 8-K-1.91%-0.48%
Form 8-K ORAMED PHARMACEUTICALS For: Feb 07SEC filing · Form 8-K+0.00%-6.44%
Form 8-K ORAMED PHARMACEUTICALS For: Jan 21SEC filing · Form 8-K+0.00%-0.43%
Form 8-K ORAMED PHARMACEUTICALS For: Jan 02SEC filing · Form 8-K+0.00%+0.41%
Form 8-K ORAMED PHARMACEUTICALS For: Dec 13SEC filing · Form 8-K+6.17%+2.13%
Form 10-Q ORAMED PHARMACEUTICALS For: Sep 30SEC filing · Form 10-Q+0.00%-2.12%
Form 8-K ORAMED PHARMACEUTICALS For: Oct 24SEC filing · Form 8-K+0.01%+4.33%
Form 8-K ORAMED PHARMACEUTICALS For: Oct 07SEC filing · Form 8-K—-1.77%
Form 8-K ORAMED PHARMACEUTICALS For: Sep 23SEC filing · Form 8-K+0.63%+3.77%
Form 8-K ORAMED PHARMACEUTICALS For: Sep 20SEC filing · Form 8-K-0.85%-1.06%
Form 10-Q ORAMED PHARMACEUTICALS For: Jun 30SEC filing · Form 10-Q-2.11%-2.08%
Form 8-K ORAMED PHARMACEUTICALS For: Aug 01SEC filing · Form 8-K+1.41%+3.76%
Form 8-K ORAMED PHARMACEUTICALS For: Jun 26SEC filing · Form 8-K-2.43%+4.05%
Form 8-K ORAMED PHARMACEUTICALS For: Jun 20SEC filing · Form 8-K+0.00%-1.76%
Form ARS ORAMED PHARMACEUTICALS For: Dec 31SEC filing · Form ARS+0.45%+0.91%
Form DEF 14A ORAMED PHARMACEUTICALS For: Aug 01SEC filing · Form DEF+0.45%+0.91%
Form 8-K ORAMED PHARMACEUTICALS For: Jun 06SEC filing · Form 8-K-0.04%-4.61%
Form 8-K ORAMED PHARMACEUTICALS For: May 10SEC filing · Form 8-K-0.42%+0.42%
Form 10-Q ORAMED PHARMACEUTICALS For: Mar 31SEC filing · Form 10-Q+0.00%+1.05%
Form 8-K ORAMED PHARMACEUTICALS For: May 02SEC filing · Form 8-K-0.42%+4.62%
Form 8-K ORAMED PHARMACEUTICALS For: Mar 14SEC filing · Form 8-K+0.00%+1.80%
Form 8-K ORAMED PHARMACEUTICALS For: Mar 12SEC filing · Form 8-K+0.00%+1.80%
Form 8-K ORAMED PHARMACEUTICALS For: Mar 18SEC filing · Form 8-K+0.00%+1.80%
Form 10-K ORAMED PHARMACEUTICALS For: Dec 31SEC filing · Form 10-K+1.07%+2.14%
Form 8-K ORAMED PHARMACEUTICALS For: Feb 20SEC filing · Form 8-K-0.32%+0.64%
Form 8-K ORAMED PHARMACEUTICALS For: Jan 22SEC filing · Form 8-K-1.27%-3.81%
Form 8-K ORAMED PHARMACEUTICALS For: Jan 17SEC filing · Form 8-K+0.89%-1.56%
Form 8-K ORAMED PHARMACEUTICALS For: Dec 21SEC filing · Form 8-K+0.91%+6.36%
Form 8-K ORAMED PHARMACEUTICALS For: Dec 18SEC filing · Form 8-K+0.00%+3.21%
Form 10-Q ORAMED PHARMACEUTICALS For: Sep 30SEC filing · Form 10-Q+0.00%-2.54%
That’s how ORMP usually reacts to SEC filings — get an email when it moves on news →
Keep exploring

More ORMP: earnings → · analyst actions → · ORMP overview →

Other Healthcare names and their SEC filings

TickerEventsMedian 30-min% positive
BeyondSpring, Inc. - Ordinary Shares (BYSI)1460.00%49%
Clearside Biomedical, Inc. (CLSD)1450.00%46%
GlycoMimetics, Inc. (GLYC)144+0.53%54%
Mustang Bio, Inc. (MBIO)144-0.46%41%

Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.